| Literature DB >> 35214163 |
Tomomi Hatanaka1,2, Khampeeraphan Ramphai3, Shun Takimoto4, Hiromi Kanda4, Nami Motosugi2, Minoru Kimura5, Tomotaka Mabuchi2, Midori Oyama1, Tomoharu Takeuchi1, Yosuke Okamura3,4.
Abstract
Xeroderma pigmentosum (XP) is a rare autosomal recessive hereditary disorder. As patients with XP are deficient in nucleotide excision repair, they show severe photosensitivity symptoms. Although skin protection from ultraviolet (UV) radiation is essential to improve the life expectancy of such patients, the optimal protective effect is not achieved even with sunscreen application, owing to the low usability of the preparations. Nanosheets are two-dimensional nanostructures with a thickness in the nanometer range. The extremely large aspect ratios of the nanosheets result in high transparency, flexibility, and adhesiveness. Moreover, their high moisture permeability enables their application to any area of the skin for a long time. We fabricated preparations containing avobenzone (BMDBM) based on freestanding poly (L-lactic acid) (PLLA) nanosheets through a spin-coating process. Although monolayered PLLA nanosheets did not contain enough BMDBM to protect against UV radiation, the layered nanosheets, consisting of five discrete BMDBM nanosheets, showed high UV absorbance without lowering the adhesive strength against skin. Inflammatory reactions in XPA-deficient mice after UV radiation were completely suppressed by the application of BMDBM-layered nanosheets to the skin. Thus, the BMDBM layered nanosheet could serve as a potential sunscreen preparation to improve the quality of life of patients with XP.Entities:
Keywords: UV protection; avobenzone; layered nanosheet; nanosheet; poly (L-lactic acid); xeroderma pigmentosum
Year: 2022 PMID: 35214163 PMCID: PMC8878169 DOI: 10.3390/pharmaceutics14020431
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Figure 1Schematic for preparation of BMDBM nanosheets. (a) BMDBM nanosheets fabricated via a spin-coating method using a sacrificial membrane. (b) BMDBM five-layered nanosheet fabricated utilizing sodium alginate as a gelling agent for the sacrificial membrane. PLLA, poly (L-lactic acid); BMDBM, 4-tert-butyl-4′-methoxydibenzoylmethane; PVA, poly (vinyl alcohol); Na-Alg, sodium alginate; Ca-Alg, calcium alginate, EDTA-2Na, ethylenediaminetetraacetic acid disodium salt.
Characteristics of BMDBM nanosheet preparations.
| Preparation | Building Blocks | Sacrificial Layers | Final Thickness e | ||
|---|---|---|---|---|---|
| PLLA a | BMDBM b | PVA c | Na-Alg d | ||
| Nanosheet | 1.0 |
| 1.0 |
| 58.7 ± 4.1 |
| BMDBM nanosheet | 1.0 | 0.5 | 1.0 |
| 77.0 ± 1.8 |
| Layered nanosheet | 1.0 |
| 1.8 | 2.5 | 360.0 ± 4.0 |
| BMDBM-layered nanosheet | 1.0 | 0.5 | 1.8 | 2.5 | 451.3 ± 71.4 |
a,b,c,d: Concentrations of poly (L-lactic acid), 4-tert-butyl-4′-methoxydibenzoylmethane (avobenzone), poly (vinyl alcohol), and sodium alginate in the spin-coating solutions, respectively. e: Each value represents the mean ± standard deviation of 3–5 measurements.
Figure 2Characterization of BMDBM nanosheet preparations. (a) Macroscopic image of a BMDBM nanosheet floating in water. Scale bar represents 1.0 cm. (b) Macroscopic image of a BMDBM-layered nanosheet floating in water. Scale bar represents 1.0 cm. (c) Sectional scanning electron microscope image of a layered nanosheet. Arrow heads indicate the discrete nonosheet layers. Scale bar represents 3.0 µm. (d) Relationship between the thickness of nanosheet and BMDBM concentration. (e) Ultraviolet visible light absorption spectra of nanosheet preparations. (f) Fourier transform infrared spectra of nanosheet preparations. Each value represents the mean ± standard deviation of 3–5 measurements. BMDBM, 4-tert-butyl-4′-methoxydibenzoylmethane (avobenzone); Na-Alg, sodium alginate; PVA, poly (vinyl alcohol).
Figure 3Protective effect of BMDBM-layered nanosheets on the appearance of XPA-deficient mice after UV exposure. After application of BMDBM-layered nanosheets or layered nanosheets (without BMDBM) on the area surrounded with dotted lines in the ear and the dorsal skin, mice were irradiated with UVB at 0.5 kJ/m2 only once. The results were representative examples of five mice in each group.
Figure 4Protective effect of the BMDBM-layered nanosheet against ear swelling and pathological findings in XPA-deficient mice after UV exposure. After application of the BMDBM-layered nanosheet or layered nanosheet on the right ear and a part of the right dorsal skin, mice were irradiated with UVB at 0.5 kJ/m2 once. (a) Ear swelling after UV exposure. Each point represents the mean ± standard deviation of data obtained from five mice. * p < 0.05 when covered right ear with BMDBM-layered nanosheet was compared to uncovered left ear. (b) Histological analysis of dorsal skin using hematoxylin and eosin 96 h after UV exposure. Images in the right column show an enlarged view of the marked area in the corresponding images in the left column. Scale bars represent 500 and 125 µm for the left and right columns, respectively. Upper and middle images show exfoliation of the skin and filtration of inflammatory cells stained with hematoxylin eosin blue. (c) Histological analysis of dorsal skin not subjected to UV irradiation using hematoxylin and eosin.